ORASURE TECHNOLOGIES INC (OSUR) Fundamental Analysis & Valuation

NASDAQ:OSUR • US68554V1089

3.19 USD
+0.21 (+6.87%)
At close: Mar 6, 2026
3.2103 USD
+0.02 (+0.64%)
After Hours: 3/6/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This OSUR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, OSUR scores 3 out of 10 in our fundamental rating. OSUR was compared to 184 industry peers in the Health Care Equipment & Supplies industry. While OSUR seems to be doing ok healthwise, there are quite some concerns on its profitability. OSUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. OSUR Profitability Analysis

1.1 Basic Checks

  • In the past year OSUR has reported negative net income.
  • OSUR had a negative operating cash flow in the past year.
  • In the past 5 years OSUR reported 4 times negative net income.
  • In multiple years OSUR reported negative operating cash flow during the last 5 years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • With a Return On Assets value of -14.24%, OSUR perfoms like the industry average, outperforming 55.98% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -16.64%, OSUR is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • OSUR has a worse Gross Margin (40.41%) than 66.85% of its industry peers.
  • OSUR's Gross Margin has declined in the last couple of years.
  • OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OSUR Health Analysis

2.1 Basic Checks

  • OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • OSUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • OSUR has an Altman-Z score of 2.07. This is not the best score and indicates that OSUR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.07, OSUR is doing good in the industry, outperforming 61.41% of the companies in the same industry.
  • OSUR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • OSUR has a better Debt to Equity ratio (0.00) than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.07
ROIC/WACCN/A
WACC10.13%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • OSUR has a Current Ratio of 7.03. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
  • OSUR has a Current ratio of 7.03. This is amongst the best in the industry. OSUR outperforms 86.96% of its industry peers.
  • A Quick Ratio of 6.20 indicates that OSUR has no problem at all paying its short term obligations.
  • The Quick ratio of OSUR (6.20) is better than 88.04% of its industry peers.
Industry RankSector Rank
Current Ratio 7.03
Quick Ratio 6.2
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. OSUR Growth Analysis

3.1 Past

  • OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -257.69%.
EPS 1Y (TTM)-257.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28.53%

3.2 Future

  • Based on estimates for the next years, OSUR will show a very strong growth in Earnings Per Share. The EPS will grow by 28.70% on average per year.
  • OSUR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.32% yearly.
EPS Next Y23.23%
EPS Next 2Y15.37%
EPS Next 3Y28.7%
EPS Next 5YN/A
Revenue Next Year2.71%
Revenue Next 2Y5.21%
Revenue Next 3Y10.32%
Revenue Next 5YN/A

3.3 Evolution

OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. OSUR Valuation Analysis

4.1 Price/Earnings Ratio

  • OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • OSUR's earnings are expected to grow with 28.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.37%
EPS Next 3Y28.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OSUR Dividend Analysis

5.1 Amount

  • No dividends for OSUR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OSUR Fundamentals: All Metrics, Ratios and Statistics

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (3/6/2026, 8:00:02 PM)

After market: 3.2103 +0.02 (+0.64%)

3.19

+0.21 (+6.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners86.51%
Inst Owner Change-3.94%
Ins Owners5.58%
Ins Owner Change0.29%
Market Cap228.82M
Revenue(TTM)N/A
Net Income(TTM)-60.24M
Analysts80
Price Target4.59 (43.89%)
Short Float %5.97%
Short Ratio7.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS1.75
BVpS5.05
TBVpS4.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.24%
ROE -16.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.41%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.29%
Cap/Sales 2.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.03
Quick Ratio 6.2
Altman-Z 2.07
F-Score2
WACC10.13%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-257.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.86%
EPS Next Y23.23%
EPS Next 2Y15.37%
EPS Next 3Y28.7%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28.53%
Revenue Next Year2.71%
Revenue Next 2Y5.21%
Revenue Next 3Y10.32%
Revenue Next 5YN/A
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-91.42%
EBIT Next 3Y-4.12%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%

ORASURE TECHNOLOGIES INC / OSUR FAQ

What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to OSUR.


What is the valuation status of ORASURE TECHNOLOGIES INC (OSUR) stock?

ChartMill assigns a valuation rating of 1 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.


Can you provide the profitability details for ORASURE TECHNOLOGIES INC?

ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OSUR stock?

The Earnings per Share (EPS) of ORASURE TECHNOLOGIES INC (OSUR) is expected to grow by 23.23% in the next year.